Results 241 to 250 of about 874,843 (291)

Case Report: a 28-year-old female patient presented with recurrent fevers and episodes of shock due to <i>ZBTB24</i> pathogenic variant. [PDF]

Front Immunol
Gao J, Jiang X, Tian Y, Zhai R, Chen Y, Guo J, Wu L, Hu M.   +7 more
europepmc   +1 more source

Pharmacokinetic modelling of intravenous immunoglobulin in children with primary immunodeficiencies and secondary antibody deficiencies

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Children with primary immunodeficiency (PID) and secondary antibody deficiency (SAD) often require immunoglobulin replacement therapy due to low plasma immunoglobulin G (IgG) levels and recurrent infections. Existing pharmacokinetic models for immunoglobulin in PID patients predominantly focus on adults, with limited attention to ...
Iek Leng Cheng, Zhong Hui Huang, Austen Worth, Claire Booth, Joseph F. Standing   +4 more
wiley   +1 more source

Rapidly Progressive Disseminated Bacillus Calmette-Guérin Infection (BCGitis) in a 3-Month-Old Infant Without Immunodeficiency: A Case Report. [PDF]

Am J Case Rep
Perillo NQ, Heliodoro T, De Camargo LA, Gomes Avelino MA, Bahmad F.   +4 more
europepmc   +1 more source

Global efforts to address severe acute malnutrition.

, 2012
Ahmed, Tahmeed, Brewster, David, Caton, Harmony, Desjeux, Jehan-François, Forbes, David, Hossain, Muttaquina, Kleinman, Ronald E, Uauy, Ricardo   +7 more
core   +1 more source

Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous–venous extracorporeal membrane oxygenation (VV‐ECMO): A case report

British Journal of Clinical Pharmacology, EarlyView.
While providing potentially life‐saving cardiorespiratory support for critically ill patients, extracorporeal membrane oxygenation (ECMO) may detrimentally affect pharmacokinetic (PK) performance and concurrent drug efficacy and safety. We describe a patient with Pneumocystis jirovecii pneumonia (PJP) in the context of acquired immunodeficiency ...
Tom C. Zwart, Emiel Leegwater, Thomas H. Ottens, Emile F. Schippers, Erik B. Wilms, David M. Burger, Cees van Nieuwkoop, Liesbeth B. E. Bosma   +7 more
wiley   +1 more source

Demographic, clinical, and immunological features in combined immunodeficiency patients: a comparative analysis of those with and without pulmonary manifestations - a multicenter study from Iran. [PDF]

BMC Pulm Med
Khanbabaee G, Pourghasem M, Jamee M, Tabatabaii SA, Khalili M, Sharafian S, Mesdaghi M, Sadeghi-Shabestari M, Shirvani A, Sadr S, Zahmatkesh A, Delavari S, Eslami N, Farahbakhsh N, Mansouri M, Tabiei E, Modarresi SZ, Behbahani AT, Eslamian G, Fallahi M, Enayat J, Fallah S, Pourghasem M, Aghamohammadi A, Chavoshzadeh Z.   +24 more
europepmc   +1 more source

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

Severe <i>Salmonella</i> Infections in AIGAs Immunodeficiency Syndrome: Hyperinflammation and Immune Dysregulation. [PDF]

Infect Drug Resist
Liang S, Chen F, Huang X, Ning Y, Wu S, Hong L, Chen N, Liang H, Wang M, Liang X, He Z.   +10 more
europepmc   +1 more source

Carrier‐free self‐assembled nanomedicine for combination‐therapy of acute myeloid leukemia

BMEMat, EarlyView.
CPDS combines drugs with three different mechanisms of action to achieve a multi‐mechanism combination therapy for AML by directly killing tumor cells and activating anti‐tumor immunity. Abstract As the main acute myeloid leukemia (AML) clinical treatment, the chemotherapy alone cannot meet the clinical therapeutic needs due to the high heterogeneity ...
Meihong Chai, Rui Zhang, Haiyin Yang, Jiyue Xing, Tianyuan Hu, Mengxi Zhu, Rui Li, Xiaoli Chen, Beibei Zhao, Yang Lan, Stefan Barth, Yuanyu Huang, Li Zhang, Mengjie Zhang, Huining He   +14 more
wiley   +1 more source